As one of the country's large exporting industries, the medical device industry has been hit by the appreciation of the U.S. dollar, which makes exports more expensive and imports cheaper.
St. Jude Medical released new data from a trial that showed patients using its CardioMEMS HF system had a 57% reduction in mortality and 43% fewer hospitalizations related to heart failure compared to patients treated only by guideline directed medical therapy.
St. Jude Medical's transcatheter aortic valve replacement, or TAVR, cardiology device is now commercially available in Europe once again, after its CE mark was suspended following safety concerns about reduced valve leaflet mobility arising from the company's U.S. clinical trials.
Remote monitoring can empower patients and lead to more fine-tuning of care while saving hospitals money and helping hospitals meet their Affordable Care Act goals. Sales of remote-monitoring devices are expected to top $32 billion this year, according to Market Research Group, and will grow at a compounded annual growth rate of 9.2% between 2014 and 2019.
St. Jude Medical is starting a trial for a device that it hopes will be the smallest FDA-approved pediatric mechanical heart valve. The device is only 15 mm in diameter; that's roughly equivalent to the length of a staple.
St. Jude Medical has won FDA approval for its FlexAbility Ablation Catheter. This is the first irrigated ablation catheter with a flexible tip to be available in the U.S. The technology is used by electrophysiologists in the treatment of cardiac arrhythmias.
Boston Scientific has released one-year, retrospective data to demonstrate efficacy for its Precision Spectra Spinal Cord Stimulator in treating chronic lower back pain.
St. Jude Medical has gained approval for a quadripolar cardiac resynchronization therapy pacemaker that for the first time incorporates its MultiPoint Pacing technology that's been shown to be better for patients who don't respond to traditional biventrical pacing.
As hospitals scramble to reduce readmissions, or face punishment under the Affordable Care Act's Hospital Readmissions Reduction Program, they are increasingly turning to efficiency-promoting devices like St. Jude Medical's CardioMEMS HF System for monitoring heart failure patients.
Minnesota-based device giant St. Jude Medical is beating the bushes in Malaysia, possibly looking to expand its production and services operations there, Malaysia's New Straits Times reported.